Health Catalyst Appoints Tami Reller to Board, Driving Next Growth Phase

Tami Reller Joins Health Catalyst's Board of Directors

In a significant move aimed at bolstering its strategic leadership, Health Catalyst, Inc. has announced the appointment of Tami Reller to its board of directors. This transition is set to take effect on October 1, 2026, coinciding with a pivotal moment for the company, which aims to further its growth trajectory in the healthcare intelligence space.

As Health Catalyst embarks on its next growth phase with Simeon Kohl at the helm as Chief Executive Officer and President, Reller’s expertise will be invaluable. With an impressive history of guiding public companies, Reller will assume the role of audit chair and become a member of the compensation committee, enhancing the board's oversight and governance capacity.

Reller's Background and Expertise

Tami Reller comes to Health Catalyst with rich experience from her tenure at Duly Health and Care, one of the largest independent physician groups in the United States. Serving as President from 2021 to 2022 and then as CEO until 2023, Reller's leadership has been marked by substantial growth in a highly competitive sector. Additionally, her prior roles at Microsoft and the UnitedHealth Group underline her unique blend of technology and healthcare insight, positioning her well to address the challenges faced by health systems today.

Reller's extensive public company board experience adds another layer of expertise. As a member of the board of SPS Commerce, Inc. since 2016, she has contributed significantly, including serving on the audit and governance committees and chairing the board. Furthermore, her previous role as a board member at Avalara Inc. showcases her ability to navigate the complexities of mergers and acquisitions, an increasingly relevant skill in today's market.

Health Catalyst’s Strategic Vision

Under the leadership of Simeon Kohl, Health Catalyst is poised to continue its innovation in healthcare technology, having already established a strong foundation with 18 years of operation and $2.8 billion in validated outcomes. The company's commitment to harnessing artificial intelligence and data analytics positions it as a leading player in the burgeoning field of healthcare intelligence. With Reller's appointment, the organization is set to strengthen its strategic focus and drive impactful changes in how technology serves health systems.

Justin Spencer, Chairman of the Board, expressed enthusiasm for Reller's addition, stating, "Reller has guided public companies through periods of growth and has a wealth of financial expertise. Her experience working at the intersection of healthcare and technology aligns perfectly with our vision for the future."

Reller's Vision for Health Catalyst

In her own words, Reller highlighted the potential of Health Catalyst's technology: "I know what it takes to make technology truly deliver for a health system. Health Catalyst has the data, proven results, and direction needed to make a significant impact in healthcare. I am eager to contribute to that mission."

As Reller prepares to join the board, her insights from both the healthcare delivery and technology sectors will likely prove crucial in steering Health Catalyst through its next chapter. The integration of her strategic foresight may pave the way for innovations that enhance clinical performance while effectively managing costs in health systems.

Conclusion

The appointment of Tami Reller to Health Catalyst's board signifies a strategic alignment of skills and experiences that could fuel the company’s next phase of growth. With a solid foundation already in place, Health Catalyst aims to leverage Reller's deep industry insights to navigate the complexities of modern healthcare. As this new leadership unfolds, the healthcare sector will be watching closely to see how this collaboration transforms health system efficiencies and outcomes.